Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amplyx Pharmaceuticals
Biotech
Pfizer cuts 3 assets as R&D spend drops 24% in Q4
Pfizer is discarding three assets—one of which was the heart of a 2021 Amplyx acquisition—after R&D spending dropped 24% in the Q4.
Gabrielle Masson
Jan 30, 2024 11:37am
Pfizer buys Amplyx to grow infectious disease pipeline
Apr 28, 2021 7:45am
Pfizer, Adage bump up Amplyx's series C to top $90 million
May 19, 2020 8:10am
Amplyx nets Novartis antiviral, unveils data for lead program
Sep 16, 2019 8:00am
Amplyx raises $67M to trial broad-spectrum antifungal
Aug 2, 2017 5:00am
